TransMedics Group, Inc. (TMDX) › Shareholders' EquityTransMedics Group, Inc. (TMDX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$168.72M2018: -$192.24M2019: $54.65M2020: $103.89M2021: $67.85M2022: $187.38M2023: $137.20M2024: $228.60M2025: $473.10M$473.10M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$473.10M+107.0%2024$228.60M+66.6%2023$137.20M-26.8%2022$187.38M+176.1%2021$67.85M-34.7%2020$103.89M+90.1%2019$54.65M+128.4%2018-$192.24M-13.9%2017-$168.72M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share